Forte Research Systems, Inc., developer of specialized clinical research management software, announced that PharmaSeek, an Investigative Site Network, has implemented its Allegro Clinical Trial Management System (CTMS) to support their rapidly growing operations and help manage multiple trials running simultaneously. The investigative site network switched to the CTMS when they outgrew their existing system.
"We evaluated several CTMS systems and Forte allowed for an easy-to-use and highly-customizable platform. Forte's willingness to rely on feedback to continually make system updates and enhancements was critical in our decision making process," said Lindsay McCarthy, Director of Operations at PharmaSeek.
When beginning development of the multi-site edition of the Allegro CTMS system in 2011, Forte established collaboration with PharmaSeek so the network could provide insight and guidance with regard to the unique needs of networks.
The multi-site edition of Allegro CTMS was released in January 2012 with features such as a site database, project management tools, subject visit scheduling, and financial management functionality. After migrating all their data into the Allegro CTMS system, PharmaSeek has found the site selection and project management tools particularly useful.
"In Allegro CTMS, site selection is more streamlined than ever, allowing our team to quickly identify potential sites for new study opportunities," says McCarthy. "We are now able to quickly and easily retrieve qualified sites based on site-specific search criteria, such as therapeutic areas, phases a site can participate in, and equipment available at each site."
Additionally, contact information and documents such as investigator credentials are easily accessible, eliminating the need for repeated collection for each study protocol. The system also tracks expiration dates of these documents, so PharmaSeek can contact the site, if needed, to ensure they have the most current documents on file.
With the many activities and communications required during the study start-up process, PharmaSeek needed a way to manage all activities at each site. With Allegro CTMS, the PharmaSeek project managers are able to log in and view a dashboard for all the sites and protocols that they manage. They are also able to track metrics to gain insight into site performance across all these tasks.
McCarthy says, "Moving forward, we plan to dive deeper into Allegro CTMS, expanding the system to other areas of our organization and enabling us to manage everything from subject enrollments to budgets and payments."
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.